Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease diabetes mellitus, insulin-dependent
Phenotype |hypoglycemia
Sentences 108
PubMedID- 23912765 hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.
PubMedID- 22998689 Learning and memory deficits are common neurological sequelae following hypoglycemia in patients with type 1 diabetes and in the relatively younger population with type 2 diabetes [49-51].
PubMedID- 20650471 Conclusions: a basal insulin rate reduction was safe and effective in raising post-exercise nocturnal bg nadir and in reducing hypoglycemia in children with type 1 diabetes mellitus.
PubMedID- 23264302 Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes.
PubMedID- 24736487 A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
PubMedID- 26502880 However, as the disease progresses, patients with type 2 diabetes frequently show similar susceptibility to severe hypoglycemia as seen in patients with type 1 diabetes [6, 7].
PubMedID- 22923666 Fourth, this is the first published study to evaluate closed-loop control during exercise, a common cause of hypoglycemia in patients with type 1 diabetes (16).
PubMedID- 23835337 Indeed, 6–10% of deaths in young people with type 1 diabetes are directly attributable to hypoglycemia (15–17).
PubMedID- 22584135 Therefore, our data do not support the hypothesis that severe hypoglycemia in patients with type 1 diabetes increases the risk of cvd.
PubMedID- 22699295 The glucagon response to hypoglycemia in adolescents with type 1 diabetes is influenced by the duration of diabetes and can be lost early in the course of the disease.
PubMedID- 20587723 All measures except pai-1 were also found to be increased during hypoglycemia compared with euglycemia in type 1 diabetes.
PubMedID- 24065010 Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
PubMedID- 25964778 The above study demonstrated that significant neuroendocrine and metabolic sexual dimorphisms exist in responses to hypoglycemia in individuals with type 1 diabetes.
PubMedID- 21917871 Objective: we hypothesized that opioid receptor blockade with naloxone during antecedent hypoglycemia in patients with type 1 diabetes mellitus (t1dm) would prevent the development of haaf.
PubMedID- 21680991 Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 22180760 Assessing fear of hypoglycemia in children with type 1 diabetes and their parents.
PubMedID- 23577069 The aim of the present study is to test the effects of epo treatment on cognitive function, hypoglycemic symptoms, counter-regulatory hormonal responses and cortical electrical activity during mild hypoglycemia in patients with type 1 diabetes.
PubMedID- 20200306 Even with the use of insulin pumps and long-acting insulin analogs, severe hypoglycemia is common in patients with type 1 diabetes, especially during sleep at night.
PubMedID- 23781301 Association of igf1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 21346182 Conclusions: the hfs-ii is a reliable and valid measure of the fear of hypoglycemia in adults with type 1 diabetes, and factor analyses and irt support the two separate subscales of the survey.
PubMedID- 23589542 Landmark data on the impact of hypoglycemia on adults with type 1 diabetes come from the diabetes control and complications trial (dcct) and its follow-up study, where cognition has been systematically measured over time.
PubMedID- 21971353 Supercompensated brain glycogen may contribute to the development of hypoglycemia unawareness in patients with type 1 diabetes by providing energy for the brain during periods of hypoglycemia.
PubMedID- 23434929 Paradoxically, somatostatin concentrations are elevated at baseline and rise further during hypoglycemia in patients with type 1 diabetes mellitus who are on exogenous insulin (19).
PubMedID- 24130362 A 10-s sprint performed after moderate-intensity exercise neither increases nor decreases the glucose requirement to prevent late-onset hypoglycemia in individuals with type 1 diabetes.
PubMedID- 19703761 Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.
PubMedID- 24973438 Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.
PubMedID- 19663922 The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes.
PubMedID- 21701633 Pieber et al27 compared glycemic control and risk of hypoglycemia in patients with type 1 diabetes randomized to either twice-daily insulin detemir or once-daily insulin glargine injections, in combination with premeal aspart to demonstrate noninferiority.
PubMedID- 22374639 Conclusions: performing resistance exercise before aerobic exercise improves glycemic stability throughout exercise and reduces the duration and severity of postexercise hypoglycemia for individuals with type 1 diabetes.
PubMedID- 21868778 These data suggest that lgs has the potential to reduce nocturnal hypoglycemia in patients with type 1 diabetes at the highest risk.
PubMedID- 20929999 The epinephrine response to hypoglycemia in patients with type 1 diabetes with hypoglycemia unawareness was greater after the use of real-time cgm with low glucose alarms than with standard medical therapy alone.
PubMedID- 26019290 We have also found that performing one or several short sprints is protective against hypoglycemia in individuals with type 1 diabetes (guelfi et al.
PubMedID- 24574352 We asked: 1) what are the acute, temporal associations between mvpa and hypoglycemia in adolescents with type 1 diabetes and 2) are these associations moderated by sex, fitness, or adiposity?
PubMedID- 21216859 Overnight use improved glucose control and reduced hypoglycemia in children with type 1 diabetes (18).
PubMedID- 20190284 Long-term effect of an education program (hypos) on the incidence of severe hypoglycemia in patients with type 1 diabetes.
PubMedID- 22611064 Spontaneous nocturnal hypoglycemia in patients with type 1 diabetes results in a reduction of the low-frequency component of hr, which is best explained by excessive sympathetic activation without a concomitant withdrawal of vagal outflow.
PubMedID- 23063035 Background: self-monitoring of blood glucose (smbg) and continuous glucose monitoring (cgm) have been proven effective in improving hemoglobin a1c (hba1c) and in reducing hypoglycemia in patients with type 1 diabetes mellitus (t1dm).
PubMedID- 25288675 Conclusions: reporting of severe hypoglycemia by patients with type 1 diabetes is significantly reduced following implementation of eu driver's licensing legislation that implies withdrawal of driver's licensing in case of recurrent episodes within 1 year.
PubMedID- 20585005 The pilot study data suggest that glutamine supplementation increases the likelihood of nighttime hypoglycemia in adolescents with type 1 diabetes after performing heavy exercise.
PubMedID- 20007944 These data suggest that initiation of insulin analog treatment preconception rather than during early pregnancy may result in a lower risk of severe hypoglycemia in women with type 1 diabetes.
PubMedID- 25267512 Recurrent nocturnal hypoglycemia in a patient with type 1 diabetes mellitus.
PubMedID- 25415670 Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases.
PubMedID- 22784848 Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services.
PubMedID- 24319119 Objective: to develop and pilot a novel intervention addressing motivational and cognitive barriers to avoiding hypoglycemia in people with type 1 diabetes and persistent impaired awareness of hypoglycemia (iah) despite training in flexible insulin therapy.
PubMedID- 21284474 Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control.
PubMedID- 20920434 Conclusions: this article offers, for the first time, a method for smoothly reducing insulin delivery rate to prevent hypoglycemia in individuals with type 1 diabetes mellitus based on a mathematically formal assessment of hypoglycemic risk.
PubMedID- 20508232 Vessel wall stiffness was found to be increased during hypoglycemia in patients with type 1 diabetes of longer duration than those with a shorter duration of diabetes (53).
PubMedID- 21722581 Background: real-time continuous glucose monitoring (rt-cgm) improves hemoglobin a1c (a1c) and hypoglycemia in people with type 1 diabetes mellitus and those with type 2 diabetes mellitus (t2dm) on prandial insulin; however, it has not been tested in people with t2dm not taking prandial insulin.
PubMedID- 20332355 Objective: to minimize hypoglycemia in subjects with type 1 diabetes by automated glucagon delivery in a closed-loop insulin delivery system.
PubMedID- 21770764 Conclusions: cv and conga may be predictors of impaired glucagon responses to insulin-induced hypoglycemia in patients with type 1 diabetes.

Page: 1 2 3